sulfadiazine has been researched along with Graft vs Host Disease in 1 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brinkman, K | 1 |
| Debast, S | 1 |
| Sauerwein, R | 1 |
| Ooyman, F | 1 |
| Hiel, J | 1 |
| Raemaekers, J | 1 |
1 other study available for sulfadiazine and Graft vs Host Disease
| Article | Year |
|---|---|
Toxoplasma retinitis/encephalitis 9 months after allogeneic bone marrow transplantation.
Topics: Adult; Anti-Infective Agents; Bone Marrow Transplantation; Clindamycin; Female; Graft vs Host Diseas | 1998 |